BioNexus Gene Lab Corporation (BGLC)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Cash from Operating Activities | 544k | -119k | -140k | -1.04M | -1.3M | -34k | -704k | -2.16M |
Cash from Investing Activities | -451k | -5k | -8k | -368k | -383k | 24k | 107k | -76k |
Cash from Financing Activities | 116k | N/A | -4k | 5.74M | 5.76M | 24k | 197k | -1,000 |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | 553k | 9k | 544k | -1.3M |
Cash from Investing Activities | 1.32M | -491k | -451k | -383k |
Cash from Financing Activities | -5k | -28k | 116k | 5.76M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.